Sensitivity to the effects of a kappa opioid in rats with free access to exercise wheels: Differential effects across behavioral measures

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 1, 2004, Pages 49-57

  Smith, Mark A ^a   McClean, Jacob M ^a   Bryant, Paul A ^a  

^a DAVIDSON COLLEGE   (United States)

Author keywords

Antinociception; Conditioned place preference; Diuresis; Exercise; Kappa; Locomotor activity; Opioid; Rat; Spiradoline

Indexed keywords

POLYCARBONATE; SPIRADOLINE MESILATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL HOUSING; ANTINOCICEPTION; ARTICLE; CAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIURESIS; DRUG EFFECT; DRUG SCREENING; DRUG SELECTIVITY; DRUG SENSITIVITY; EXERCISE; LOCOMOTION; MALE; MEASUREMENT; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RANDOMIZATION; RAT; SENSITIVITY ANALYSIS; SITTING; STANDARD; WEANING;

EID: 0347285257     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.09.021     Document Type: Article

References (45)

1. Aravich P.F., Rieg T.S., Lauterio T.J., Doerries L.E. Beta-endorphin and dynorphin abnormalities in rats subjected to exercise and restricted feeding: relationship to anorexia nervosa? Brain Res. 622:1993;1-8.
2. Bals-Kubik R., Ableitner A., Herz A., Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264:1993;489-495.
3. Bhargava H.N. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opioid receptor agonist in the rat. Gen Pharmacol. 26:1995;1055-1060.
4. Bhargava H.N., Gulati A. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. Eur. J. Pharmacol. 190:1990;305-311.
5. Butelman E.R., Harris T.J., Kreek M.J. Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serum prolactin levels in rhesus monkeys. Psychopharmacology. 147:1999;73-80.
6. Cao Y.I., Bhargava H.N. Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice. Brain Res. 752:1997;250-254.
7. Collins R.I., Zavala A.R., Ingersoll V.Y., Duke M.A., Crawford C.A., McDougall S.A. Kappa opioid-mediated behavioral sensitization in the preweanling rat: relationship to Fos immunoreactivity. Psychopharmacology. 137:1998;282-291.
8. D'Anci K.E., Gerstein A.V., Kanarek R.B. Long-term voluntary access to running wheels decreases kappa-opioid antinociception. Pharmacol. Biochem. Behav. 66:2000;343-346.
9. de Castro J.M., Duncan G. Operantly conditioned running: effects on brain catecholamine concentrations and receptor densities in the rat. Pharmacol. Biochem. Behav. 23:1985;495-500.
10. del Rosario Capriles N., Cancela L.M. Motivational effects mu- and kappa-opioid agonists following acute and chronic restraint stress: involvement of dopamine D(1) and D(2) receptors. Behav. Brain Res. 132:2002;159-169.
11. Diaz A., Ruiz F., Florez J., Hurle M.A., Pazos A. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. J. Pharmacol. Exp. Ther. 274:1995;1545-1551.
12. Fontana F., Bernardi P., Merlo Pich E., Boschi S., De Iasio R., Capelli M.et al. Endogenous opioid system and atrial natriuretic factor in normotensive offspring of hypertensive parents at rest and during exercise test. J. Hypertens. 12:1994;1285-1290.
13. Funada M., Suzuki T., Narita M., Misawa M., Nagase H. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology. 32:1993;1315-1323.
14. Garzon J., Rodriguez-Diaz M., Lopez-Fando A., Garcia-Espana A., Sanchez-Blazquez P. Glycosylated phonducin-like protein long regulates opioid receptor function in mouse brain. Neuropharmacology. 42:2002;813-828.
15. Gilliam P.E., Spirduso W.W., Martin T.P., Walters T.J., Wilcox R.E., Farrar R.P. The effects of exercise training on [3H]-spiperone binding in rat striatum. Pharmacol. Biochem. Behav. 20:1984;863-867.
16. Gwynn G.J., Domino E.F. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity. J Pharmacol Exp Ther. 231:1984;306-311.
17. Horan P.J., Porreca P. Lack of cross-tolerance between U69,593 and bromazocine suggests kappa-opioid receptor multiplicity in mice. Eur J Pharmacol. 239:1993;93-98.
18. Houghten R.A., Pratt S.M., Young E.A., Brown H., Spann D.R. Effect of chronic exercise on beta-endorphin receptor levels in rats. NIDA Res. Monogr. 75:1986;505-508.
19. Institute of Laboratory Animal Resources Guide for the care and use of laboratory animals. 1996;National Academy Press, Washington, DC.
20. Janal M.N. Pain sensitivity, exercise and stoicism. J. R. Soc. Med. 89:1996;376-381.
21. Kanarek R.B., Gerstein A.V., Wildman R.P., Mathes W.F., D'Anci K.E. Chronic running-wheel activity decreases sensitivity to morphine-induced analgesia in male and female rats. Pharmacol. Biochem. Behav. 61:1998;19-27.
22. Koltyn K.F. Analgesia following exercise: a review. Sports Med. 29:2000;85-98.
23. Leander J.D. A kappa opioid effect: increased urination in the rat. J Pharmacol Exp Ther. 224:1983;89-94.
24. Lett B.T., Grant V.L., Koh M.T., Flynn G. Prior experience with wheel running produces cross-tolerance to the rewarding effect of morphine. Pharmacol. Biochem. Behav. 72:2002;101-105.
25. Looy H., Eikelboom R. Wheel running, food intake, and body weight in male rats. Physiol. Behav. 45:1989;403-405.
26. MacRae P.G., Spirduso W.W., Cartee G.D., Farrar R.P., Wilcox R.E. Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolite levels. Neurosci. Lett. 79:1987;138-144.
27. Marinelli M., Le Meal M., Piazza P.V. Sensitization to the motor effects of contingent infusions of heroin but not of kappa agonist RU-51599. Psychopharmacology,139. 139:1998;281-285.
28. Mathes W.F., Kanarek R.B. Wheel running attenuates the antinociceptive properties of morphine and its metabolite, morphine-6-glucuronide, in rats. Physiol. Behav. 74:2001;245-251.
29. Meeusen R., Thorre K., Chaouloff F., Sarre S., De Meirleir K., Ebinger G.et al. Effects of tryptophan and/or acute running on extracellular 5-HT and 5-HIAA levels in the hippocampus of food-deprived rats. Brain Res. 740:1996;245-252.
30. Nemmani K.V., Ramarao P., Giasenoside K.E. Potentiates U-50488H-induced analgesia and inhibits tolerance to its analgesic in mice. Life Sci. 72:2003;759-768.
31. O'Connor P.J., Cook D.B. Exercise and pain: the neurobiology, measurement, and laboratory study of pain in relation to exercise in humans. Exerc. Sport Sci. Rev. 27:1999;119-166.
32. Pagliari R., Peyrin L. Norepinephrine release in the rat frontal cortex under treadmill exercise: a study with microdialysis. J. Appl. Physiol. 78:1995;2121-2130.
33. Paronis C.A., Holtzman S.G. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J. Pharmacol. Exp. Ther. 262:1992;1-9.
34. Rogers N.F., el-Fakahany E. Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells. Eur. J. Pharmacol. 124:1986;221-230.
35. Salas S.P., Rebleto J.S., Lopez L.F., Tachibata S., Huldebro-Tore J.F. [N-methyl-Tyrl,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8) ethylamide, a stable dymorphin analog-produces diuresis by kappa aptale receptor activation in the rat. J. Pharmacol. Exp. Ther. 262:1992;979-986.
36. Shippenberg T.S., Herz A. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. Brain Res. 436:1987;169-172.
37. Shippenberg T.S., Herz A. Motivational effects of opioids: influence of D-1 versais D-2 receptor antagonists. Eur J. Pharmacol. 151:1988;233-242.
38. Shippenberg T.S., Bennett-Oglesby M.W., Ayesta N., Flerr A. Tolerance and selective cross-tolerance to the motivational effects of opioids. Psychopharmacology. 96:1988;110-115.
39. Smith M.A., Picker M.J. Tolerance and cross-tolerance to the rate-suppressing effects of opioids in butorphanol-treated rats: influence of maintenance dose and relative efficacy at the mu receptor. Psychopharmacology. 140:1998;57-68.
40. Smith M.A., Yancey D.L. Sensitivity to the effects of opioids in rats with free access to running wheels: mu opioid tolerance and physical dependence. Psychopharmacology. 167:2003;426-434.
41. Stafford K., Gomes A.B., Shen J., Yoburn B.C. mu-Opioid receptor downregulation contributes to opioid tolerance in vivo. Pharmacol. Biochem. Behav. 69:2001;233-237.
42. Suzuki T., Shiozaki Y., Masukawa Y., Misawa M., Naguse J. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn. J. Pharmacol. 58:1992;435-442.
43. Tallarida R.J., Murray R.B. Manual of pharmacologic calculations with computer programs. 1987;Springer, Berlin.
44. Tao P.L., Law P.Y., Loh H.H. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J. Pharmacol. Exp. Ther. 240:1987;809-816.
45. Vaupel D.B., Cone E.J., Johnson R.E., Su T.P. Kappa opioid partial agonists activity of the enkepahlalin-like pentapeptide BW9242C based on urination and in vitro studies in humans and animals. J. Pharmacol. Exp. Ther. 252:1990;225-234.